James W Griffith1, Alisa J Stephens-Shields2, Xiaoling Hou2, Bruce D Naliboff2, Michel Pontari2, Todd C Edwards2, David A Williams2, J Quentin Clemens2, Niloofar Afari2, Frank Tu2, R Brett Lloyd2, Donald L Patrick2, Chris Mullins2, John W Kusek2, Siobhan Sutcliffe2, Barry A Hong2, H Henry Lai2, John N Krieger2, Catherine S Bradley2, Jayoung Kim2, J Richard Landis2. 1. Northwestern University (JWG, RBL), Chicago, Illinois; NorthShore University HealthSystem (FT), Chicago, Illinois; University of Chicago (FT), Chicago, Illinois; University of Pennsylvania (AJS-S, XH, JRL), Philadelphia, Pennsylvania; Temple University (MP), Philadelphia, Pennsylvania; University of California-Los Angeles (BDN), Los Angeles, California; Cedars-Sinai Medical Center (JK), Los Angeles, California; University of California-San Diego and Veterans Affairs Center of Excellence for Stress and Mental Health, San Diego (NA), California; University of Washington (TCE, JNK), Seattle, Washington; University of Michigan (DAW, JQC), Ann Arbor, Michigan; National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health (CM, JWK), Bethesda, Maryland; Washington University in St. Louis (SS, BAH, HHL), St. Louis, Missouri; University of Iowa (CSB), Iowa City, Iowa. Electronic address: j-griffith@northwestern.edu. 2. Northwestern University (JWG, RBL), Chicago, Illinois; NorthShore University HealthSystem (FT), Chicago, Illinois; University of Chicago (FT), Chicago, Illinois; University of Pennsylvania (AJS-S, XH, JRL), Philadelphia, Pennsylvania; Temple University (MP), Philadelphia, Pennsylvania; University of California-Los Angeles (BDN), Los Angeles, California; Cedars-Sinai Medical Center (JK), Los Angeles, California; University of California-San Diego and Veterans Affairs Center of Excellence for Stress and Mental Health, San Diego (NA), California; University of Washington (TCE, JNK), Seattle, Washington; University of Michigan (DAW, JQC), Ann Arbor, Michigan; National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health (CM, JWK), Bethesda, Maryland; Washington University in St. Louis (SS, BAH, HHL), St. Louis, Missouri; University of Iowa (CSB), Iowa City, Iowa.
Abstract
PURPOSE: The purpose of this study was to create symptom indexes, that is scores derived from questionnaires to accurately and efficiently measure symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively referred to as urological chronic pelvic pain syndromes. We created these indexes empirically by investigating the structure of symptoms using exploratory factor analysis. MATERIALS AND METHODS: As part of the MAPP (Multi-Disciplinary Approach to the Study of Chronic Pelvic Pain) Research Network 424 participants completed questionnaires, including GUPI (Genitourinary Pain Index), ICSI (Interstitial Cystitis Symptom Index) and ICPI (Interstitial Cystitis Problem Index). Individual items from questionnaires about bladder and pain symptoms were evaluated by principal component and exploratory factor analyses to identify indexes with fewer questions to comprehensively quantify symptom severity. Additional analyses included correlating symptom indexes with symptoms of depression, which is a known comorbidity of patients with pelvic pain. RESULTS AND CONCLUSIONS: Exploratory factor analyses suggested that the 2 factors pain severity and urinary severity provided the best psychometric description of items in GUPI, ICSI and ICPI. These factors were used to create 2 symptom indexes for pain and urinary symptoms. Pain, but not urinary symptoms, was associated with symptoms of depression on multiple regression analysis, suggesting that these symptoms may impact patients with urological chronic pelvic pain syndromes differently (B ± SE for pain severity = 0.24 ± 0.04, 95% CI 0.16-0.32, β = 0.32, p <0.001). Our results suggest that pain and urinary symptoms should be assessed separately rather than combined into 1 total score. Total scores that combine the separate factors of pain and urinary symptoms into 1 score may be limited for clinical and research purposes.
PURPOSE: The purpose of this study was to create symptom indexes, that is scores derived from questionnaires to accurately and efficiently measure symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively referred to as urological chronic pelvic pain syndromes. We created these indexes empirically by investigating the structure of symptoms using exploratory factor analysis. MATERIALS AND METHODS: As part of the MAPP (Multi-Disciplinary Approach to the Study of Chronic Pelvic Pain) Research Network 424 participants completed questionnaires, including GUPI (Genitourinary Pain Index), ICSI (Interstitial Cystitis Symptom Index) and ICPI (Interstitial Cystitis Problem Index). Individual items from questionnaires about bladder and pain symptoms were evaluated by principal component and exploratory factor analyses to identify indexes with fewer questions to comprehensively quantify symptom severity. Additional analyses included correlating symptom indexes with symptoms of depression, which is a known comorbidity of patients with pelvic pain. RESULTS AND CONCLUSIONS: Exploratory factor analyses suggested that the 2 factors pain severity and urinary severity provided the best psychometric description of items in GUPI, ICSI and ICPI. These factors were used to create 2 symptom indexes for pain and urinary symptoms. Pain, but not urinary symptoms, was associated with symptoms of depression on multiple regression analysis, suggesting that these symptoms may impact patients with urological chronic pelvic pain syndromes differently (B ± SE for pain severity = 0.24 ± 0.04, 95% CI 0.16-0.32, β = 0.32, p <0.001). Our results suggest that pain and urinary symptoms should be assessed separately rather than combined into 1 total score. Total scores that combine the separate factors of pain and urinary symptoms into 1 score may be limited for clinical and research purposes.
Authors: J Quentin Clemens; Elizabeth A Calhoun; Mark S Litwin; Mary McNaughton-Collins; John W Kusek; Evelyn M Crowley; J Richard Landis Journal: Urology Date: 2009-10-02 Impact factor: 2.649
Authors: Björn Riegel; Christian A Bruenahl; Sascha Ahyai; Ulrike Bingel; Margit Fisch; Bernd Löwe Journal: J Psychosom Res Date: 2014-09-30 Impact factor: 3.006
Authors: J Richard Landis; David A Williams; M Scott Lucia; Daniel J Clauw; Bruce D Naliboff; Nancy A Robinson; Adrie van Bokhoven; Siobhan Sutcliffe; Anthony J Schaeffer; Larissa V Rodriguez; Emeran A Mayer; H Henry Lai; John N Krieger; Karl J Kreder; Niloofar Afari; Gerald L Andriole; Catherine S Bradley; James W Griffith; David J Klumpp; Barry A Hong; Susan K Lutgendorf; Dedra Buchwald; Claire C Yang; Sean Mackey; Michel A Pontari; Philip Hanno; John W Kusek; Chris Mullins; J Quentin Clemens Journal: BMC Urol Date: 2014-08-01 Impact factor: 2.264
Authors: Adelle Dagher; Adam Curatolo; Monisha Sachdev; Alisa J Stephens; Chris Mullins; J Richard Landis; Adrie van Bokhoven; Andrew El-Hayek; John W Froehlich; Andrew C Briscoe; Roopali Roy; Jiang Yang; Michel A Pontari; David Zurakowski; Richard S Lee; Marsha A Moses Journal: BJU Int Date: 2017-04-11 Impact factor: 5.588
Authors: Andrew Schrepf; Bruce Naliboff; David A Williams; Alisa J Stephens-Shields; J Richard Landis; Arpana Gupta; Emeran Mayer; Larissa V Rodriguez; Henry Lai; Yi Luo; Catherine Bradley; Karl Kreder; Susan K Lutgendorf Journal: Ann Behav Med Date: 2018-09-13
Authors: J Quentin Clemens; Alisa Stephens-Shields; Bruce D Naliboff; H Henry Lai; Larissa Rodriguez; John N Krieger; David A Williams; John W Kusek; J Richard Landis Journal: J Urol Date: 2018-01-04 Impact factor: 7.450
Authors: J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis Journal: Nat Rev Urol Date: 2019-03 Impact factor: 14.432
Authors: Maria Teresa Sáenz Robles; Paul G Cantalupo; Alexis M Duray; Melissa Freeland; Michelle Murkowski; Adrie van Bokhoven; Alisa J Stephens-Shields; James M Pipas; Michael J Imperiale Journal: Virus Genes Date: 2020-05-23 Impact factor: 2.332
Authors: Siobhan Sutcliffe; Thomas Jemielita; H Henry Lai; Gerald L Andriole; Catherine S Bradley; J Quentin Clemens; Robert Gallop; Thomas M Hooton; Karl J Kreder; John N Krieger; John W Kusek; Jennifer Labus; M Scott Lucia; Sean Mackey; Bruce D Naliboff; Nancy A Robinson; Larissa V Rodriguez; Alisa Stephens-Shields; Adrie van Bokhoven; Kathleen Y Wolin; Yan Yan; Claire C Yang; J Richard Landis; Graham A Colditz Journal: J Urol Date: 2017-12-27 Impact factor: 7.450
Authors: Bruce D Naliboff; Alisa J Stephens; H Henry Lai; James W Griffith; J Quentin Clemens; Susan Lutgendorf; Larissa V Rodriguez; Craig Newcomb; Siobhan Sutcliffe; Wensheng Guo; John W Kusek; J Richard Landis Journal: J Urol Date: 2017-05-18 Impact factor: 7.450
Authors: J Quentin Clemens; Jason J Kutch; Emeran A Mayer; Bruce D Naliboff; Larissa V Rodriguez; David J Klumpp; Anthony J Schaeffer; Karl J Kreder; Daniel J Clauw; Steven E Harte; Andrew D Schrepf; David A Williams; Gerald L Andriole; H Henry Lai; Dedra Buchwald; M Scott Lucia; Adrie van Bokhoven; Sean Mackey; Robert M Moldwin; Michel A Pontari; Alisa J Stephens-Shields; Chris Mullins; J Richard Landis Journal: Neurourol Urodyn Date: 2020-06-23 Impact factor: 2.696
Authors: Christopher E Forsmark; Dana K Andersen; John T Farrar; Megan Golden; Aida Habtezion; Sohail Z Husain; Liang Li; Julia Mayerle; Stephen J Pandol; Aliye Uc; Zixi Zhu; Dhiraj Yadav Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Jason J Kutch; Jennifer S Labus; Richard E Harris; Katherine T Martucci; Melissa A Farmer; Sonja Fenske; Connor Fling; Eric Ichesco; Scott Peltier; Bogdan Petre; Wensheng Guo; Xiaoling Hou; Alisa J Stephens; Chris Mullins; Daniel J Clauw; Sean C Mackey; A Vania Apkarian; J Richard Landis; Emeran A Mayer Journal: Pain Date: 2017-06 Impact factor: 6.961